Laboratory of Genome Stability Maintenance, National Cancer Center Research Institute, Tsukiji, Chuo-ku, Tokyo 104-0045, Japan.
Department of Applied Chemistry, Faculty of Science, Tokyo University of Science, Kagurazaka, Shinjuku-ku, Tokyo 162-8601, Japan.
Int J Mol Sci. 2021 Nov 12;22(22):12254. doi: 10.3390/ijms222212254.
Many cancers develop as a consequence of genomic instability, which induces genomic rearrangements and nucleotide mutations. Failure to correct DNA damage in DNA repair defective cells, such as in and mutated backgrounds, is directly associated with increased cancer risk. Genomic rearrangement is generally a consequence of erroneous repair of DNA double-strand breaks (DSBs), though paradoxically, many cancers develop in the absence of DNA repair defects. DNA repair systems are essential for cell survival, and in cancers deficient in one repair pathway, other pathways can become upregulated. In this review, we examine the current literature on genomic alterations in cancer cells and the association between these alterations and DNA repair pathway inactivation and upregulation.
许多癌症是由于基因组不稳定导致的,这种不稳定性会诱导基因组重排和核苷酸突变。在 和 突变背景等 DNA 修复缺陷细胞中,如果不能纠正 DNA 损伤,就会直接增加癌症风险。基因组重排通常是 DNA 双链断裂(DSB)错误修复的结果,尽管矛盾的是,许多癌症在没有 DNA 修复缺陷的情况下也会发生。DNA 修复系统对细胞存活至关重要,在缺乏一种修复途径的癌症中,其他途径可能会被上调。在这篇综述中,我们研究了癌症细胞中基因组改变的最新文献,以及这些改变与 DNA 修复途径失活和上调之间的关联。